This article reviews the clinical and molecular risk factors for myeloproliferative neoplasms-associated splanchnic vein thrombosis, with particular focus on the possible mechanisms of splanchnic vein thrombosis formation in patients with myeloproliferative neoplasms.
Ther Adv Hematol